In-Stent Restenosis Treated With Stent-Based Delivery of Paclitaxel Incorporated in a Slow-Release Polymer Formulation - TAXUS III

Description:

TAXUS III was a single-arm, two-center study evaluating the feasibility and safety of the TAXUS NIRx paclitaxel-eluting stent in the treatment of in-stent restenosis (ISR).